A BPC-157 peptide dosage chart covering units, mg, and 10mg reconstitution math, plus safety notes and why this peptide is not FDA-approved for human use.
There is no officially approved BPC-157 peptide dosage chart. BPC-157 has not been approved by the U.S. Food and Drug Administration for human use, so no standard dose, schedule, or conversion table exists — only ranges reported in animal studies and community write-ups. Most charts you see online simply convert a 250–500 mcg dose into insulin-syringe units based on how much bacteriostatic water was added to the vial.
What a BPC-157 Peptide Dosage Chart Actually Contains
A dosage chart is a conversion tool, not a prescription. It links four numbers together: the amount of peptide in the vial, the volume of diluent you add, the resulting concentration, and the syringe units that deliver a given dose.
- Vial size: usually 5 mg or 10 mg of lyophilized powder.
- Diluent volume: the milliliters of bacteriostatic water injected into the vial.
- Concentration: milligrams (or micrograms) per milliliter after mixing.
- Syringe units: where the plunger sits on a U-100 insulin syringe for the target amount.
If you are still figuring out the basics of this compound, read what is bpc 157 peptide before you worry about numbers. Understanding what the peptide is and how it has been studied makes the math easier to sanity-check.
BPC-157 Dosage in Units: The Conversion Math
Almost every BPC-157 dosage in units question comes down to one fact about insulin syringes: on a U-100 syringe, 1 unit equals 0.01 mL.
Use this two-step formula:
- Concentration (mcg/mL) = milligrams in the vial ÷ mL of water added × 1,000.
- Units to draw = target dose (mcg) ÷ concentration (mcg/mL) ÷ 0.01.
Example: a 10 mg vial reconstituted with 2 mL of water gives 5 mg/mL, or 5,000 mcg/mL. That means each unit on the syringe delivers 50 mcg, so a 250 mcg dose is 5 units and a 500 mcg dose is 10 units.
| Water added to a 10 mg vial | Concentration | Units for 250 mcg | Units for 500 mcg |
|---|---|---|---|
| 1 mL | 10 mg/mL (10,000 mcg/mL) | 2.5 units | 5 units |
| 2 mL | 5 mg/mL (5,000 mcg/mL) | 5 units | 10 units |
| 3 mL | 3.33 mg/mL (3,333 mcg/mL) | 7.5 units | 15 units |
| 5 mL | 2 mg/mL (2,000 mcg/mL) | 12.5 units | 25 units |
On a U-100 insulin syringe, 1 unit equals 0.01 mL, so 250 mcg of a 5 mg/mL solution equals 5 units. That single conversion resolves most of the confusion in online dosage charts.
BPC-157 10mg Reconstitution Dosage Options
The bpc-157 10mg reconstitution dosage you choose is really a choice about concentration. More water means a larger injection volume for the same dose, which is easier to measure accurately but harder to inject comfortably.
- 1 mL: very concentrated; small doses land between syringe markings.
- 2 mL: the most common community reference point; about 50 mcg per unit.
- 3 mL: finer dose control; about 33 mcg per unit.
- 5 mL: easiest measurement, largest injection volume.
An online bpc-157 dosage calculator for beginners can handle this arithmetic, but it is worth learning the formula so you can verify the output yourself. Searches for a bpc-157 dosage calculator for weight loss reflect a misunderstanding of the research: BPC-157 is not a weight-loss drug, and no human trial supports that use.
Do not confuse a calculator with a recommendation. A calculator only converts units and volume; it cannot tell you whether a dose is safe or appropriate for you.
Commonly Referenced BPC-157 Dosage Ranges
The ranges below appear in animal studies and community write-ups. They are shown for context only and are not an approved schedule.
| Context | Commonly cited amount | Frequency |
|---|---|---|
| General research literature (rodent models) | 10 mcg/kg | Once daily |
| Community subcutaneous protocols | 250–500 mcg | Once or twice daily |
| Localized injection protocols | 250–500 mcg near the site | Once daily |
| Oral capsule protocols (unverified absorption) | 250–500 mcg | Once or twice daily |
A bpc-157 dosage chart by weight is frequently requested, but no human study has established weight-based dosing for BPC-157. Rodent studies use micrograms per kilogram, and people often copy that number directly, which is not a valid conversion.
Human pharmacokinetic data for BPC-157 is extremely limited, so every figure above should be treated as unverified.
BPC-157 and TB-500 Dosage for Injury: How Stack Charts Differ
Community protocols frequently combine BPC-157 with TB-500, a fragment of thymosin beta-4. A bpc-157 and tb-500 dosage for injury chart usually lists two very different dose scales, because TB-500 is discussed in milligrams while BPC-157 is discussed in micrograms.
| Peptide | Commonly cited amount | Frequency | Typical route |
|---|---|---|---|
| BPC-157 | 250–500 mcg | Once or twice daily | Subcutaneous or local |
| TB-500 (thymosin beta-4 fragment) | 2–2.5 mg | Twice weekly | Subcutaneous |
Mixing the two scales is the most common math error in stacking. TB-500 amounts are roughly 5 to 10 times larger by mass than BPC-157 amounts, so a single syringe conversion table will not work for both compounds.
No controlled human trial has shown that a BPC-157 and TB-500 combination is safe or effective for injury. Both peptides are sold as research chemicals, not as medicines.
Safety, Sourcing, and Beginner Mistakes
BPC-157 is not FDA-approved for human use in the United States. Products sold online are labeled "for research use only," and their purity, sterility, and actual contents are not verified by any regulator.
Anyone searching for where to buy bpc-157 peptide should understand that sourcing is the largest uncontrolled variable in any protocol. Independent third-party testing is uncommon, and mislabeled vials are a recurring problem in the research-chemical market.
Common beginner errors include:
- Drawing with a U-40 syringe while calculating in U-100 units.
- Forgetting how much water was added and guessing the concentration.
- Assuming a larger amount is stronger or faster-acting.
- Skipping sterile technique or reusing needles.
- Ignoring interactions with prescription medications.
Talk to a licensed healthcare professional before injecting any research peptide. A clinician can review your medical history, your current medications, and any symptoms that a peptide might mask.
Self-experimentation with unapproved peptides carries real risk, including injection-site reactions, unknown immune responses, and no regulatory safety net if something goes wrong.
Frequently Asked Questions
What is a typical BPC-157 dosage in units?
It depends entirely on how much water you added to the vial. With a 10 mg vial mixed with 2 mL of bacteriostatic water, the concentration is 5 mg/mL, so 250 mcg equals 5 units and 500 mcg equals 10 units on a U-100 syringe. No FDA-approved human dose exists.
How do you reconstitute a 10 mg BPC-157 vial?
Add bacteriostatic water slowly down the inside wall of the vial, then swirl gently instead of shaking. Adding 2 mL produces a 5 mg/mL concentration, which is the most common reference point in community write-ups. Use a fresh alcohol swab and a new needle each time.
Is a BPC-157 dosage calculator for weight loss useful?
No. BPC-157 has never been studied in humans as a weight-loss agent, and no dosage chart for weight loss is supported by evidence. Calculators only convert units and volume, so they cannot validate the underlying dose or its purpose. Anyone considering peptides for weight loss should speak with a healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.